Elevance Health stock is trading -7.37% below its average target price of $578.22 after marking a 5.2% during today's morning session. Analysts are giving the Large-Cap Medical Specialities company an average rating of buy and target prices ranging from $537.0 to $629.0 per share.
Elevance Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 0.9%. The stock's short ratio is 2.22. The company's insiders own 0.21% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 92.2%. In conclusion, we believe there is mixed market sentiment regarding Elevance Health.
Institutions Invested in Elevance Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-12-31 | Vanguard Group Inc | 9% | 21,227,190 | $11,368,858,782 |
| 2023-12-31 | Blackrock Inc. | 9% | 21,030,599 | $11,263,568,571 |
| 2023-12-31 | Price (T.Rowe) Associates Inc | 5% | 11,923,593 | $6,386,038,142 |
| 2023-12-31 | State Street Corporation | 4% | 10,409,617 | $5,575,182,850 |
| 2023-12-31 | Wellington Management Group, LLP | 3% | 5,910,392 | $3,165,487,848 |
| 2023-12-31 | Geode Capital Management, LLC | 2% | 4,517,729 | $2,419,605,375 |
| 2023-12-31 | Sanders Capital, LLC | 2% | 4,457,986 | $2,387,608,218 |
| 2023-12-31 | FMR, LLC | 2% | 3,965,986 | $2,124,102,849 |
| 2023-12-31 | Ameriprise Financial, Inc. | 2% | 3,711,807 | $1,987,969,656 |
| 2023-12-31 | Capital International Investors | 1% | 3,374,709 | $1,807,426,703 |
